OnabotulinumtoxinA in elderly patients with chronic migraine: insights from a real-life European multicenter study.
Claudia AltamuraRaffaele OrnelloFayyaz AhmedAndrea NegroA M MiscioA SantoroAlicia AlpuenteA RussoM SilvestroSabina CevoliNicoletta BrunelliLicia GrazziBaraldi CarloSimona GuerzoniAnna P AndreouGiorgio LambruI FrattaleK KammRuth RuscheweyhMarco RussoPaola TorelliE FilatovaNina V LatyshevaA Gryglas-DworakMarcin StraburzyńskiC ButeraB ColomboMassimo FilippiPatricia Pozo-RosichPaolo MartellettiSimona SaccoFabrizio VernieriPublished in: Journal of neurology (2022)
In a population of elderly CM patients with a long history of migraine OBT-A provided a significant benefit, over the first three treatment cycles, as good as in non-old patients.